Results 91 to 100 of about 5,559 (204)

Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This study investigated drug–drug interactions in patients with atrial fibrillation taking both a direct oral anticoagulant (DOAC) and an antiarrhythmic drug.
Victor Chien‐Chia Wu, Chun‐Li Wang, Yu‐Chang Huang, Hui‐Tzu Tu, Yu‐Tung Huang, Chang‐Fu Kuo, Shao‐Wei Chen, Kuo‐Chun Hung, Ming‐Shien Wen, Shang‐Hung Chang   +9 more
doaj   +1 more source

Capillary electrophoretic investigation of the enantioselective metabolism of propafenone by human cytochrome P-450 SUPERSOMES: Evidence for atypical kinetics by CYP2D6 and CYP3A4

, 2006
An enantioselective CE method was used to identify the ability of CYP450 enzymes and their stereoselectivity in catalyzing the transformation of propafenone (PPF) to 5-hydroxy-propafenone (5OH-PPF) and N-despropyl-propafenone (NOR-PPF).
Thormann, Wolfgang, Afshar, Minoo
core   +1 more source

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation

Кардиоваскулярная терапия и профилактика, 2006
Aim. To study the effects of three-month propafenone antiarrhythmic therapy (daily dose 450 mg) on inotropic myocardial function in patients with recurrent atrial fibrillation (AF). Material and methods.
I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzhsky   +2 more
doaj  

Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia

, 1984
Electrophysiologic and hemodynamic studies were performed before and after intravenous infusion of a new antiarrhythmic agent, propafenone, in 28 patients with recurrent ventricular tachycardia.
Shapiro, William, Schwartz, Alan B., Scheinman, Melvin M., Shen, Edward N., Sung, Ruey J., Morady, Fred, Dicarlo, Lorenzo   +6 more
core   +1 more source

Intravenous propafenone for conversion of atrial fibrillation or flutter to sinus rhythm: A randomized, placebo-controlled, crossover study

, 1997
Background: Propafenone has been claimed to be effective in converting atrial fibrillation and flutter to sinus rhythm; however, controlled clinical trials have reported variable results, and data about the safety of propafenone in the setting of heart ...
TOKAY TARHAN, SENA
core   +1 more source

Ensanchamiento del complejo QRS: ¿hiperkalemia? ¿propafenona?

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2012
RESUMEN La hiperkalemia y la propafenona  son condiciones que enlentecen la velocidad de conducción intracardiaca. Se presenta  una paciente que en el curso de una hiperkalemia moderada y con dosis bajas de propafenona mostró una taquicardia sinusal con
Marleny Cruz Cardentey, Margarita Dorantes Sánchez, Annerys Méndez Rosabal   +2 more
doaj  

Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review)

Сучасні медичні технології
Aim: to analyze the pharmacological features and updated evidence-based medicine data of Class IC antiarrhythmic drug (AAD) ethacizine compared to propafenone to optimize the choice of treatment for cardiac arrhythmias in patients without structural ...
N. M. Sydorova, M. Yu. Kolesnyk
doaj   +1 more source

Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia

, 1985
The effects of the antiarrhythmic agent propafenone were evaluated in 25 patients with recurrent symptomatic ventricular tachycardia. Oral propafenone was given to a maximal dose of 300 mg every 8 hours.
Chilson, Donald A., Zipes, Douglas P., Prystowsky, Eric N., Browne, Kevin F., Heger, James J.   +4 more
core   +1 more source

Reduced progression of atrial fibrillation in hypertensive patients with long-term treatment of propafenone

КардиоСоматика, 2016
In recent years, progress has been made in the study of the natural history of atrial fibrillation (AF) - that, from the stage of having no clinical manifestations, to the final stage, which is an irreversible arrhythmia, is associated with the ...
A. I Tarzimanova, V. I Podzolkov
doaj  

Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators

, 1996
Objectives.The effects of propafenone, a predominantly class IC antiarrhythmic drug, on defibrillation and pacing thresholds were evaluated in patients undergoing cardioverter-defibrillator implantation.Background.Previous studies have shown that the ...
Stevens, Stephanie K., Schwartz, Kerry M., Packer, Douglas L., Kowey, Peter R., Haffajee, Charles I., Naccarelli, Gerald V., Luceri, Richard M., Rubin, Andrew M.   +7 more
core   +1 more source